Open AccessAdditional L-Carnitine Reduced the Risk of Hospitalization in Patients with Overt Hepatic Encephalopathy on Rifaximin
Author(s) -
Kousuke Kubota,
Haruki Uojima,
Xue Shao,
Shigeo Iwasaki,
Hiroyoshi Hidaka,
Naohisa Wada,
Takahide Nakazawa,
Akitaka Shibuya,
Makoto Kako,
Wasaburo Koizumi
Publication year - 2021
Publication title -
digestive diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.879
H-Index - 66
eISSN - 1421-9875
pISSN - 0257-2753
DOI - 10.1159/000518067
Subject(s) - rifaximin , medicine , gastroenterology , hepatic encephalopathy , group b , randomized controlled trial , carnitine , encephalopathy , cirrhosis , antibiotics , biochemistry , chemistry
Data regarding the additional effect on the recurrence of hepatic encephalopathy (HE) after oral L-carnitine administration are scarce.